BIRC5 and colorectal carcinoma: Specifically, we began to demonstrate that Obatoclax transcriptionally downregulated survivin in multiple human CRC cell lines, illustrating survivin downregulation is a general mode of action of Obatoclax (Figure 1 and Figure 2).